Detection of cytokeratin 20 mRNA in the peripheral blood of patients with colorectal cancer by immunomagnetic bead enrichment and real-time reverse transcriptase-polymeras chain reaction

被引:23
|
作者
Guo, JM
Xiao, BX
Jin, ZJ
Qin, LJ
Chen, J
Chen, H
Zhang, XJ
Liu, Z
机构
[1] Ningbo Univ, Sch Med, Ningbo 315211, Peoples R China
[2] Ningbo Univ, Sch Med Affiliated Hosp, Ningbo 315211, Peoples R China
[3] Ningbo Med Mol Diagnost Ctr, Ningbo, Peoples R China
关键词
colorectal cancer; cytokeratin; 20; immunomagnetic beads; peripheral blood; reverse transcriptase-polymerase chain reaction;
D O I
10.1111/j.1440-1746.2005.03894.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: Detection of circulating cancer cells is a useful indicator for, the risk of recurrence of advanced carcinoma. The aim of the present study was to evaluate the potential value of a novel approach to detect the circulating cancer cells in patients with colorectal cancer. This method is based on a combination of isolation of epithelial cell by a combination of negative and positive immunomagnetic beads with detection of cytokeratin 20 (CK20) mRNA by reverse transcriptase-polymeras chain reaction (RT-PCR). Methods: Peripheral blood samples were collected from 40 patients with colorectal carcinoma on the day before operation or chemical therapy. Mononuclear cells (MNC) were isolated by centrifugation through a Ficoll gradient. Each MNC sample was equally divided into three parts and then CD45 immunomagnetic beads and/or Ber-EP4 immunomagnetic beads were used to enrich colon cancer cells. Finally, the CK20 mRNA was detected by real-time quantitative RT-PCR. As a control, LS174T colon cancer cells were serially diluted with blood from healthy individuals. Results: When CD45 and Ber-EP4 immunomagnetic beads were used successively, a significant correlation between CK20 mRNA levels and the initial cell concentrations was found in the control recovery experiment. The sensitivity of the assay was one cancer cell in 1 mL healthy blood. In the patient group, CK20 mRNA was detected in 80.0%, 82.5% and 72.5% of patients when CD45, Ber-EP4, and CD45/ Ber-EP4 immunomagnetic beads were used, respectively. The positive detection rates of patients with colorectal carcinoma at Dukes A, B, C, and D stage were 0.0% (0/2), 33.3% (3/9), 86.7% (13/15), and 92.9% (13/14), respectively. The CK20 mRNA positive detection rate in peripheral blood was significantly correlated with tumor diameter (P < 0.0 1, chi(2)), lymphatic metastasis (P < 0.05) and hepatic metastasis (P < 0.05), but not with the differentiation of tumor cells. Conclusion: The combined use of negative and positive immunomagnetic beads followed by amplification of CK20 mRNA by means of RT-PCR is a non-invasive, sensitive, and specific assay for the detection of circulating colonic cancer cells. (C) 2005 Blackwell Publishing Asia Pty Ltd.
引用
收藏
页码:1279 / 1284
页数:6
相关论文
共 50 条
  • [1] Critical evaluation of real-time reverse transcriptase-polymerase chain reaction for the quantitative detection of cytokeratin 20 mRNA in colorectal cancer patients
    Dandachi, N
    Balic, M
    Stanzer, S
    Halm, M
    Resel, M
    Hinterleitner, TA
    Samonigg, H
    Bauernhofer, T
    [J]. JOURNAL OF MOLECULAR DIAGNOSTICS, 2005, 7 (05): : 631 - 637
  • [2] Detection of colorectal cancer cells in peripheral blood by reverse-transcriptase polymerase chain reaction for cytokeratin 20
    Wyld, DK
    Selby, P
    Perren, TJ
    Jonas, SK
    Allen-Mersh, TG
    Wheeldon, J
    Burchill, SA
    [J]. INTERNATIONAL JOURNAL OF CANCER, 1998, 79 (03) : 288 - 293
  • [3] Quantitative detection of cytokeratin 20 mRNA expression in bladder carcinoma by real-time reverse transcriptase-polymerase chain reaction
    Christoph, F
    Müller, M
    Schostak, M
    Soong, R
    Tabiti, K
    Miller, K
    [J]. UROLOGY, 2004, 64 (01) : 157 - 161
  • [4] Specific detection of cytokeratin 20-positive cells in blood of colorectal and breast cancer patients by a high sensitivity real-time reverse transcriptase-polymerase chain reaction method
    Giribaldi, G
    Procida, S
    Ulliers, D
    Mannu, F
    Volpatto, R
    Mandili, G
    Fanchini, L
    Bertetto, O
    Fronda, G
    Simula, L
    Rimini, E
    Cherchi, G
    Bonello, L
    Maule, MM
    Turrini, F
    [J]. JOURNAL OF MOLECULAR DIAGNOSTICS, 2006, 8 (01): : 105 - 112
  • [5] DETECTION OF CYTOKERATIN 20 (CK-20) IN PERIPHERAL BLOOD FROM COLORECTAL CANCER PATIENTS USING REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION (RT-PCR)
    Volpatto, R.
    Procida, S.
    Giribaldi, G.
    Sandrucci, S.
    Mussa, A.
    Fronda, G.
    De Paolis, P.
    Fanchini, L.
    Racca, P.
    Bertetto, O.
    [J]. ANNALS OF ONCOLOGY, 2004, 15 : 44 - 45
  • [6] Reverse transcriptase/polymerase chain reaction detection of cytokeratin-19 mRNA in bone marrow and blood of breast cancer patients
    Kruger, W
    Krzizanowski, C
    Holweg, M
    Stockschlader, M
    Kroger, N
    Jung, R
    Mross, K
    Jonat, W
    Zander, AR
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1996, 122 (11) : 679 - 686
  • [7] Detection of colonic cells in peripheral blood of colorectal cancer patients by means of reverse transcriptase and polymerase chain reaction
    Castells, A
    Boix, L
    Bessa, X
    Gargallo, L
    Piqué, JM
    [J]. BRITISH JOURNAL OF CANCER, 1998, 78 (10) : 1368 - 1372
  • [8] Detection of colonic cells in peripheral blood of colorectal cancer patients by means of reverse transcriptase and polymerase chain reaction
    A Castells
    L Boix
    X Bessa
    L Gargallo
    JM Piqué
    [J]. British Journal of Cancer, 1998, 78 : 1368 - 1372
  • [9] Detection of colorectal carcinoma cells in circulating peripheral blood by reverse transcription polymerase chain reaction targeting cytokeratin-20 mRNA
    Funaki, NO
    Tanaka, JJ
    Itami, A
    Kasamatsu, T
    Ohshio, GJ
    Onodera, H
    Monden, K
    Okino, T
    Imamura, M
    [J]. LIFE SCIENCES, 1997, 60 (09) : 643 - 652
  • [10] Quantitative detection of cytokeratin 20 mRNA expression in bladder carcinoma by real-time reverse transcrieptase-polymerase chain reaction
    Yilmaz, Sunde
    Biray, R.
    Dogan, Zeynep Ozlem
    Nazl, Oktay
    Gunduz, Cumhur
    [J]. CELLULAR ONCOLOGY, 2007, 29 (02) : 169 - 169